Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991;104(2):249-54.
doi: 10.1007/BF02244187.

Differential effects of anxiogenic central and peripheral benzodiazepine receptor ligands in tests of learning and memory

Affiliations

Differential effects of anxiogenic central and peripheral benzodiazepine receptor ligands in tests of learning and memory

P V Holmes et al. Psychopharmacology (Berl). 1991.

Abstract

Previous research has demonstrated that low doses of anxiogenic central benzodiazepine receptor (CBR) ligands, the beta-carbolines, improve performance in various learning and memory tests in animals if administered prior to training. The present experiments compared the effect of a beta-carboline (FG 7142) with that of a pharmacologically distinct anxiogenic compound, a peripheral benzodiazepine receptor (PBR) ligand, 4'-chlorodiazepam (Ro5-4864), in two tests of learning and memory in rats. As expected, FG 7142 significantly improved performance in a passive avoidance test. Ro5-4864 was without effect. In a shuttlebox escape test, Ro5-4864 significantly impaired performance while FG 7142 had no effect. The effect of Ro5-4864 was antagonized by the specific peripheral benzodiazepine receptor antagonist, PK 11195. These results indicate that the differential impact of CBR and PBR anxiogenic ligands on performance in aversively-motivated learning tests may be a reflection of their distinct pharmacologies.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Pharmacol Biochem Behav. 1988 Aug;30(4):1015-20 - PubMed
    1. Annu Rev Pharmacol Toxicol. 1979;19:531-45 - PubMed
    1. Eur J Pharmacol. 1985 Oct 29;117(1):51-60 - PubMed
    1. Life Sci. 1980 Nov 17;27(20):1881-8 - PubMed
    1. Psychopharmacology (Berl). 1986;88(3):336-40 - PubMed

Publication types